Efficacy of combined treatment with lanreotide and cabergoline in selected therapy-resistant acromegalic patients. | Pituitary;1(2): 115-20, 1999. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Efficacy of combined treatment with lanreotide and cabergoline in selected therapy-resistant acromegalic patients.

Marzullo, P; Ferone, D; Di Somma, C; Pivonello, R; Filippella, M; Lombardi, G; Colao, A.

Affiliation

Marzullo P; Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Naples, Italy.

Pituitary ; 1(2): 115-20, 1999.

Article in En | MEDLINE | ID: mdl-11081189

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Peptides, Cyclic / Acromegaly / Somatostatin / Dopamine Agonists / Ergolines Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Pituitary Journal subject: ENDOCRINOLOGIA Year: 1999 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Peptides, Cyclic / Acromegaly / Somatostatin / Dopamine Agonists / Ergolines Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Pituitary Journal subject: ENDOCRINOLOGIA Year: 1999 Document type: Article Affiliation country: Country of publication: